Skip to main content
. 2024 Feb 8;6(1):vdae019. doi: 10.1093/noajnl/vdae019

Table 5:

Patient Reported Outcomes at Presentation via Risk survey

LTS STS
N = 20
n (%)
N = 61
n (%)
Number of symptom categories reported by patient at presentation 1 4 (20) 18 (30)
2 or more 16 (80) 39 (64)
Time with symptoms before presentation N = 23 N = 72
No symptoms 0 (0) 1 (1)
<6 months 17 (74) 53 (71)
6 months to 1 year 5 (22) 5 (7)
>1 year 0 (0) 3 (4)
Don’t recall 1 (4) 10 (14)
Symptom category
N = 20 N = 61
Seizures 3 (15) 13 (23)
Headaches 10 (50) 23 (38)
Vision problems 1 (5) 6 (10)
Hearing loss 1 (5) 1 (2)
Taste/smell changes 1 (5) 3 (5)
Facial numbness 0 (0) 4 (7)
Memory problems/confusion 5 (25) 22 (36)
Nausea/vomiting 4 (20) 4 (7)
Personality/behavior changes 3 (15) 6 (10)
Difficulty with balance/coordination/walking 6 (30) 15 (25)
Speech difficulties 2 (10) 12 (20)
Difficulty swallowing 2 (10) 1 (2)
Weakness in arms or legs 5 (25) 12 (20)
Sensory changes in arms or legs 2 (10) 9 (15)
Fatigue 1 (5) 0 (0)
Pain 0 (0) 1 (2)
Dizziness/loss of consciousness 0 (0) 2 (3)
Other 0 (0) 1 (2)
No symptoms 0 (0) 2 (3)
Don’t recall 0 (0) 1 (2)